Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Cocrystal Pharma, Inc. (COCP)
USD0.96
+0.02 (+2.10%)
US NASDAQ Healthcare Biotechnology
Address
19805 North Creek Parkway 98011
Bothell, WA, US
Bothell, WA, US
CEO
Sam Lee
Website
cocrystalpharma.com
IPO
2012-02-22
CIK 1412486 ISIN US19188J4094
Description
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV), influenza, coronaviruses, and noroviruses. Its current pipeline includes CC-31244, a non-nucleoside polymerase inhibitor for HCV, which has successfully completed Phase IIa clinical trials. Additionally, CC-42344, a PB2 inhibitor designed to combat influenza, is currently undergoing preclinical development. Cocrystal Pharma is also actively pursuing the development of non-nucleoside polymerase inhibitors to address norovirus infections. The company maintains strategic alliances, including a research and licensing collaboration with Merck Sharp & Dohme Corp. for the discovery and development of proprietary influenza A/B antiviral agents. It also holds a licensing agreement with the Kansas State University Research Foundation, aimed at advancing antiviral compounds for norovirus and coronavirus infections. Furthermore, Cocrystal Pharma engages in drug discovery collaborations with both HitGen and InterX Inc. The company's operations are headquartered in Bothell, Washington.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.96
+0.02 (+2.10%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.41
Float Shares
6.77M
Free Float %
66.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.76% | -14.29% | -20.53% | +29.03% | +17.65% | +22.57% | -14.89% | -50.00% | -91.07% | -99.48% | -99.87% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
0.96
DCF (Unlevered)
0.47
-50.6%
DCF (Levered)
0.49
-49.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-66.11
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+54.7% ★ Q1'26: +26.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%— Q1'26: -1,040.0% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%— Q1'26: -1,047.1% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-1,112.1% Q1'26: -1,102.2% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+11.0% Q1'26: +35.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.17× Q1'26: -0.16× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 EPS Ana. |
Dec 2027 1 EPS Ana. |
Dec 2028 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
2.01M
est: 2.00M (+0.7%)
|
—
est: 2.50M (-100.0%)
|
—
est: 2.00M (-100.0%)
|
—
— – —
-100.0% YoY
|
—
— – —
|
—
— – —
|
| EBITDA |
-9.43M
est: 1.20M (-885.8%)
|
-17.75M
|
-8.64M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-9.59M
est: 1.20M (-898.8%)
|
-17.88M
|
-9.02M
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-9.65M
est: -24.42M (+60.5%)
|
-17.50M
est: -21.73M (+19.5%)
|
-8.83M
est: -8.92M (+1.0%)
|
-7.56M
-8.24M – -6.89M
+15.2% YoY
|
-7.23M
-7.23M – -7.23M
+4.5% YoY
|
-7.90M
-7.90M – -7.90M
-9.4% YoY
|
| SGA |
5.57M
est: 2.71M (+105.7%)
|
5.34M
|
3.96M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-2.01
est: -2.40 (+16.3%)
|
-1.72
est: -1.93 (+10.9%)
|
-0.78
est: -0.80 (+1.9%)
|
-0.67
-0.73 – -0.61
+15.7% YoY
|
-0.64
-0.64 – -0.64
+4.5% YoY
|
-0.70
-0.70 – -0.70
-9.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-7.78M
OE per share TTM
-0.68
Owner's Yield
-47.03%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
107.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
13
Total invested
431.8K
Insider transactions (90d)
0
Beneficial owners (>5%)
23
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Raymond F. Schinazi | 272.96M | 38.90% | — | 272.96M | 272.96M | 10.00 | IN | 6. Citizenship or Place of Organization | 2014-12-05 | ↗ |
| 2 | Bracrystal Pharmaceuticals, LLC | 26.80M | 3.80% | — | 26.80M | 26.80M | 10.00 | OO | 6. Citizenship or Place of Organization | 2014-12-05 | ↗ |
| 3 | Gary Wilcox | 16.84M | 2.40% | — | 16.84M | 16.84M | 10.00 | IN | 6. Citizenship or Place of Organization | 2014-12-05 | ↗ |
| 4 | Roger Kornberg | 15.29M | 2.20% | — | 15.29M | 15.29M | 10.00 | IN | 6. Citizenship or Place of Organization | 2014-12-05 | ↗ |
| 5 | Sam Lee | 15.29M | 2.20% | — | 15.29M | 15.29M | 10.00 | IN | 6. Citizenship or Place of Organization | 2014-12-05 | ↗ |
| 6 | 19188J300 | 9.74M | 9.00% | — | 9.74M | — | 9.74M | OO | Cayman Islands | 2021-05-12 | ↗ |
| 7 | S | 6.52M | 6.69% | 6.52M | — | 6.52M | — | CO | Cayman Islands | 2021-05-17 | ↗ |
| 8 | UMB BANK, n.a. ("UMB") | 3.70M | 7.00% | 63.63M | — | 63.63M | — | BK | Delaware | 2017-05-10 | ↗ |
| 9 | Phillip Frost, M.D. | 3.70M | 5.40% | 3.70M | — | 3.70M | 10.00 | IN | — | 2020-11-19 | ↗ |
| 10 | Barry Honig | 3.66M | 2.90% | 3.66M | — | 3.66M | — | IN | United States | 2015-02-13 | ↗ |
| 11 | Frost Gamma Investments Trust | 3.66M | 5.30% | 3.66M | — | 3.66M | 10.00 | OO | — | 2020-11-19 | ↗ |
| 12 | CVI Investments, Inc. | 3.46M | 7.30% | — | 3.46M | — | 3.46M | CO | Cayman Islands | 2020-03-06 | ↗ |
| 13 | OPKO Health, Inc. | 2.66M | 3.90% | 2.66M | — | 2.66M | 10.00 | CO | — | 2020-11-19 | ↗ |
| 14 | 13-3127734 | 1.90M | 1.95% | 1.42M | — | 1.90M | — | HC | Delaware | 2022-02-10 | ↗ |
| 15 | 26-0385758 | 1.90M | 1.95% | 1.42M | — | 1.90M | — | IA | Delaware | 2022-02-10 | ↗ |
| 16 | 1,633,035 | 1.63M | 4.20% | — | 1.63M | — | 1.63M | OO | The Netherlands | 2020-02-28 | ↗ |
| 17 | GRQ Consultants, Inc. Roth 401k Plan | 1.45M | 1.22% | — | 1.45M | — | 1.45M | CO | Florida | 2014-02-14 | ↗ |
| 18 | Barry and Renee Honig Charitable Foundation, Inc | 1.43M | 2.04% | — | 1.43M | — | 1.43M | CO | United States | 2013-09-12 | ↗ |
| 19 | Fred Hassan | 1.02M | 10.00% | 1.02M | — | — | — | IN | OR PLACE OF ORGANIZATION | 2023-04-12 | ↗ |
| 20 | 10 | 830.5K | 2.10% | — | 830.5K | — | 830.5K | OO | The Netherlands | 2020-02-28 | ↗ |
| 21 | Steven D. Rubin | 64.2K | 0.10% | 64.2K | — | 64.2K | 10.00 | IN | — | 2020-11-19 | ↗ |
| 22 | Heights Capital Management, Inc. | — | 0.00% | — | — | — | — | CO | Cayman Islands | 2021-02-16 | ↗ |
| 23 | Wasatch Advisors, Inc. 87-0319391 | — | 0.00% | — | — | — | — | IA | — | 2020-03-03 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
13
-13 vs prev Q
New positions
2
Closed positions
15
Increased
5
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 264.0K -4.1K (-1.5%) | 258.4K -76.7K (-22.9%) | 2.40% -0.233 pp | 0.00% +0.000 pp | USD1.95 -49.7% | 13 qtrs — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 126.0K -1.9K (-1.5%) | 123.4K -36.5K (-22.8%) | 1.15% -0.111 pp | 0.00% +0.000 pp | USD1.96 -50.0% | 13 qtrs — |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 82.5K +8.6K (+11.6%) | 80.8K -11.7K (-12.6%) | 0.75% +0.024 pp | 0.00% +0.000 pp | USD1.84 -46.7% | 13 qtrs — |
| 4 | BLACKROCK, INC. | 73.7K +— (+0.0%) | 72.2K -20.0K (-21.7%) | 0.67% -0.054 pp | 0.00% +0.000 pp | USD1.76 -44.3% | 6 qtrs — |
| 5 | — | 52.3K +52.3K (+100.0%) | 51.2K +51.2K (+100.0%) | 0.48% +0.476 pp | 0.06% +0.064 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 6 | DRW SECURITIES, LLC | 33.6K +33.6K (+100.0%) | 32.9K +32.9K (+100.0%) | 0.31% +0.306 pp | 0.00% +0.001 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 7 | NEUBERGER BERMAN GROUP LLC | 31.9K +— (+0.0%) | 31.2K -8.6K (-21.7%) | 0.29% -0.023 pp | 0.00% +0.000 pp | USD1.25 -21.6% | 4 qtrs — |
| 8 | STATE STREET CORP | 20.5K +— (+0.0%) | 20.1K -5.6K (-21.7%) | 0.19% -0.015 pp | 0.00% +0.000 pp | USD1.95 -49.7% | 13 qtrs — |
| 9 | XTX TOPCO LTD | 15.1K +15.1K (+100.0%) | 14.8K +14.8K (+100.0%) | 0.14% +0.138 pp | 0.00% +0.000 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 10 | TWO SIGMA SECURITIES, LLC | 12.8K +12.8K (+100.0%) | 12.5K +12.5K (+100.0%) | 0.12% +0.116 pp | 0.00% +0.002 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 11 | PARALLEL ADVISORS, LLC | 12.6K -42.0 (-0.3%) | 12.3K -3.5K (-21.9%) | 0.11% -0.010 pp | 0.00% 0.000 pp | USD1.76 -44.3% | 6 qtrs — |
| 12 | NORTHERN TRUST CORP | 11.9K +— (+0.0%) | 11.7K -3.2K (-21.7%) | 0.11% -0.009 pp | 0.00% +0.000 pp | USD1.95 -49.7% | 13 qtrs — |
| 13 | JANE STREET GROUP, LLC | 10.6K -10.4K (-49.5%) | 10.4K -15.9K (-60.5%) | 0.10% -0.110 pp | 0.00% +0.000 pp | USD1.25 -21.6% | 2 qtrs — |
| 14 | BANK OF AMERICA CORP /DE/ | 9.1K -9.0 (-0.1%) | 8.9K -2.5K (-21.8%) | 0.08% -0.007 pp | 0.00% +0.000 pp | USD1.95 -49.7% | 13 qtrs — |
| 15 | TOWER RESEARCH CAPITAL LLC (TRC) | 5.1K +1.8K (+54.6%) | 5.0K +869.0 (+21.1%) | 0.05% +0.014 pp | 0.00% +0.000 pp | USD1.34 -26.9% | 13 qtrs — |
| 16 | FORTITUDE FAMILY OFFICE, LLC | 3.2K +3.2K (+100.0%) | 3.2K +3.2K (+100.0%) | 0.03% +0.029 pp | 0.00% +0.001 pp | USD0.98 +0.0% | 1 qtrs NEW |
| 17 | UBS GROUP AG | 1.8K +1.2K (+211.2%) | 1.7K +1.0K (+143.7%) | 0.02% +0.011 pp | 0.00% +0.000 pp | USD1.18 -16.9% | 13 qtrs — |
| 18 | MORGAN STANLEY | 948.00 -4.9K (-83.8%) | 928.00 -6.4K (-87.3%) | 0.01% -0.049 pp | 0.00% +0.000 pp | USD1.90 -48.4% | 13 qtrs — |
| 19 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 817.00 +— (+0.0%) | 800.00 -221.0 (-21.6%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD1.76 -44.3% | 6 qtrs — |
| 20 | WELLS FARGO & COMPANY/MN | 788.00 -1.0K (-56.5%) | 772.00 -1.5K (-65.9%) | 0.01% -0.011 pp | 0.00% +0.000 pp | USD1.49 -34.2% | 5 qtrs — |
| 21 | CLEAN YIELD GROUP | 418.00 +— (+0.0%) | 409.00 -114.0 (-21.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.76 -44.3% | 6 qtrs — |
| 22 | CITIGROUP INC | 390.00 -663.0 (-63.0%) | 382.00 -934.0 (-71.0%) | 0.00% -0.007 pp | 0.00% +0.000 pp | USD1.25 -21.6% | 2 qtrs — |
| 23 | MAI CAPITAL MANAGEMENT | 237.00 +— (+0.0%) | 233.00 -64.0 (-21.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.02 -51.5% | 5 qtrs — |
| 24 | NVWM, LLC | 84.00 +— (+0.0%) | 82.00 -23.0 (-21.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.94 -49.5% | 13 qtrs — |
| 25 | SBI SECURITIES CO., LTD. | 33.00 -1.0 (-2.9%) | 32.00 -11.0 (-25.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.97 -50.3% | 5 qtrs — |
| 26 | ROOT FINANCIAL PARTNERS, LLC | 7.00 +7.0 (+100.0%) | 7.00 +7.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.86 +14.0% | 1 qtrs NEW |
| 27 | BARCLAYS PLC | — -16.0 (-100.0%) | — -20.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 11 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 187.2K | 0.05% |
| 2 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 444.65 | 0.03% |
| 3 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 1.2K | 0.17% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 90.18 | 0.17% |
| 5 | Vanguard Total Stock Market ETF VTI | 0.00% | 208.6K | 0.03% |
| 6 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 456.85 | 0.22% |
| 7 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 248.58 | 0.22% |
| 8 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 100.38 | 0.22% |
| 9 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 11.05 | 0.22% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 1.57 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
10
Sells
0
Shares acquired
283.3K
Shares disposed
—
Cash buys
2.00
Cash sales
—
Net activity
+283,328
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-24 | FROST PHILLIP MD ET AL | Director / 10% Owner | P-Purchase | A | Common Stock | 20,000 | 1.00 | 20.0K | 1,908,551 | I | ↗ |
| 2026-02-06 | FROST PHILLIP MD ET AL | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 0.95 | 47.3K | 1,888,551 | I | ↗ |
| 2026-01-09 | Rubin Steven D | Director | A-Award | A | Stock Options (Right to Buy) | 16,410 | 1.10 | 18.1K | 16,410 | D | ↗ |
| 2026-01-09 | PFENNIGER RICHARD C JR | Director | A-Award | A | Stock Options (Right to Buy) | 16,410 | 1.10 | 18.1K | 16,410 | D | ↗ |
| 2026-01-09 | Martin James Joseph | Officer | A-Award | A | Stock Options (Right to Buy) | 49,229 | 1.10 | 54.2K | 49,229 | D | ↗ |
| 2026-01-09 | Lee Sam | Officer | A-Award | A | Stock Options (Right to Buy) | 49,229 | 1.10 | 54.2K | 49,229 | D | ↗ |
| 2026-01-09 | Kornberg Roger D. | Director | A-Award | A | Stock Options (Right to Buy) | 24,615 | 1.10 | 27.1K | 24,615 | D | ↗ |
| 2026-01-09 | Japour Anthony J | Director | A-Award | A | Stock Options (Right to Buy) | 16,410 | 1.10 | 18.1K | 16,410 | D | ↗ |
| 2026-01-09 | Hassan Fred | Director | A-Award | A | Stock Options (Right to Buy) | 16,410 | 1.10 | 18.1K | 16,410 | D | ↗ |
| 2026-01-09 | FROST PHILLIP MD ET AL | Director / 10% Owner | A-Award | A | Stock Options (Right to Buy) | 24,615 | 1.10 | 27.1K | 24,615 | D | ↗ |
| 2025-12-31 | FROST PHILLIP MD ET AL | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 0.95 | 47.3K | 1,838,551 | I | ↗ |
| 2025-12-30 | FROST PHILLIP MD ET AL | Director / 10% Owner | P-Purchase | A | Common Stock | 20,000 | 0.97 | 19.3K | 1,788,551 | I | ↗ |
| 2025-12-26 | FROST PHILLIP MD ET AL | Director / 10% Owner | P-Purchase | A | Common Stock | 40,000 | 0.97 | 38.9K | 1,768,551 | I | ↗ |
| 2025-12-24 | FROST PHILLIP MD ET AL | Director / 10% Owner | P-Purchase | A | Common Stock | 25,000 | 0.97 | 24.3K | 1,728,551 | I | ↗ |
| 2025-11-26 | FROST PHILLIP MD ET AL | Director / 10% Owner | P-Purchase | A | Common Stock | 2,500 | 0.99 | 2.5K | 1,703,551 | I | ↗ |
| 2025-11-25 | FROST PHILLIP MD ET AL | Director / 10% Owner | P-Purchase | A | Common Stock | 20,000 | 0.94 | 18.8K | 1,699,551 | I | ↗ |
| 2025-10-28 | PFENNIGER RICHARD C JR | Director | A-Award | A | Warrants | 40,000 | 1.24 | 49.6K | 40,000 | D | ↗ |
| 2025-10-28 | Martin James Joseph | Officer | A-Award | A | Warrants | 7,196 | 1.24 | 8.9K | 7,196 | D | ↗ |
| 2025-10-28 | Hassan Fred | Director | A-Award | A | Warrants | 719,426 | 1.24 | 892.1K | 719,426 | D | ↗ |
| 2025-10-28 | FROST PHILLIP MD ET AL | Director / 10% Owner | A-Award | A | Warrants | 719,426 | 1.24 | 892.1K | 719,426 | I | ↗ |
| 2024-10-09 | Rubin Steven D | Director | A-Award | A | Common Stock | 18,957 | 0.00 | — | 2,660,242 | D | ↗ |
| 2024-10-09 | PFENNIGER RICHARD C JR | Director | A-Award | A | Common Stock | 8,067 | 0.00 | — | 11,400 | D | ↗ |
| 2024-10-09 | Martin James Joseph | Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 40,569 | D | ↗ |
| 2024-10-09 | Lee Sam | Officer | A-Award | A | Common Stock | 40,000 | 0.00 | — | 76,355 | D | ↗ |
| 2024-10-09 | Kornberg Roger D. | Director | A-Award | A | Common Stock | 28,109 | 0.00 | — | 28,109 | D | ↗ |
| 2024-10-09 | Japour Anthony J | Director | A-Award | A | Common Stock | 14,924 | 0.00 | — | 14,924 | D | ↗ |
| 2024-10-09 | Hassan Fred | Director | A-Award | A | Common Stock | 8,067 | 0.00 | — | 1,023,296 | D | ↗ |
| 2024-10-09 | FROST PHILLIP MD ET AL | Director / 10% Owner | A-Award | A | Common Stock | 27,100 | 0.00 | — | 27,100 | D | ↗ |
| 2023-07-18 | Rubin Steven D | Director | A-Award | A | Stock Options (Right to Buy) | 17,233 | 2.67 | 46.0K | 17,233 | — | ↗ |
| 2023-07-18 | PFENNIGER RICHARD C JR | Director | A-Award | A | Stock Options (Right to Buy) | 7,333 | 2.67 | 19.6K | 7,333 | — | ↗ |
| 2023-07-18 | Martin James Joseph | Officer | A-Award | A | Stock Options (Right to Buy) | 30,000 | 2.67 | 80.1K | 30,000 | — | ↗ |
| 2023-07-18 | Lee Sam | Officer | A-Award | A | Stock Options (Right to Buy) | 30,000 | 2.67 | 80.1K | 30,000 | — | ↗ |
| 2023-07-18 | Kornberg Roger D. | Director | A-Award | A | Stock Options (Right to Buy) | 24,417 | 2.67 | 65.2K | 24,417 | — | ↗ |
| 2023-07-18 | Japour Anthony J | Director | A-Award | A | Stock Options (Right to Buy) | 13,567 | 2.67 | 36.2K | 13,567 | — | ↗ |
| 2023-07-18 | Hassan Fred | Director | A-Award | A | Stock Options (Right to Buy) | 7,333 | 2.67 | 19.6K | 7,333 | — | ↗ |
| 2023-07-18 | FROST PHILLIP MD ET AL | Director / 10% Owner | A-Award | A | Stock Options (Right to Buy) | 19,333 | 2.67 | 51.6K | 19,333 | — | ↗ |
| 2023-04-20 | Hassan Fred | Director | — | D | Common Stock | 0 | 0.00 | — | 1,015,229 | — | ↗ |
| 2023-04-04 | FROST PHILLIP MD ET AL | Director / 10% Owner | P-Purchase | A | Common Stock | 1,015,229 | 1.97 | 2.00M | 1,319,838 | — | ↗ |
| 2022-07-25 | Rubin Steven D | Director | A-Award | A | Stock Options (Right to Buy) | 188,000 | 0.00 | — | 188,000 | — | ↗ |
| 2022-07-25 | PFENNIGER RICHARD C JR | Director | A-Award | A | Stock Options (Right to Buy) | 80,000 | 0.00 | — | 80,000 | — | ↗ |
| 2022-07-25 | Martin James Joseph | Officer | A-Award | A | Stock Options (Right to Buy) | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2022-07-25 | Lee Sam | Officer | A-Award | A | Stock Options (Right to Buy) | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2022-07-25 | Kornberg Roger D. | Director | A-Award | A | Stock Options (Right to Buy) | 280,000 | 0.42 | 117.6K | 280,000 | — | ↗ |
| 2022-07-25 | Japour Anthony J | Director | A-Award | A | Stock Options (Right to Buy) | 148,000 | 0.00 | — | 148,000 | — | ↗ |
| 2022-07-25 | FROST PHILLIP MD ET AL | Director | A-Award | A | Stock Options (Right to Buy) | 220,000 | 0.00 | — | 220,000 | — | ↗ |
| 2021-08-20 | PFENNIGER RICHARD C JR | Director | P-Purchase | A | Common Stock | 40,000 | 1.03 | 41.1K | 40,000 | — | ↗ |
| 2021-07-16 | Rubin Steven D | Director | A-Award | A | Stock Options (Right to Buy) | 88,000 | 1.11 | 97.7K | 88,000 | — | ↗ |
| 2021-07-16 | PFENNIGER RICHARD C JR | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 1.11 | 55.5K | 50,000 | — | ↗ |
| 2021-07-16 | Martin James Joseph | Officer | A-Award | A | Stock Options (Right to Buy) | 250,000 | 1.11 | 277.5K | 250,000 | — | ↗ |
| 2021-07-16 | Lee Sam | Officer | A-Award | A | Stock Options (Right to Buy) | 250,000 | 1.11 | 277.5K | 250,000 | — | ↗ |
| 2021-07-16 | Kornberg Roger D. | Director | A-Award | A | Stock Options (Right to Buy) | 65,000 | 1.11 | 72.2K | 65,000 | — | ↗ |
| 2021-07-16 | Japour Anthony J | Director | A-Award | A | Stock Options (Right to Buy) | 74,000 | 1.11 | 82.1K | 74,000 | — | ↗ |
| 2021-07-16 | FROST PHILLIP MD ET AL | Director | A-Award | A | Stock Options (Right to Buy) | 65,000 | 1.11 | 72.2K | 65,000 | — | ↗ |
| 2021-05-27 | PFENNIGER RICHARD C JR | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-05-04 | Schinazi Raymond F | 10% Owner | S-Sale | D | Common Stock | 575,000 | 2.95 | 1.70M | 7,674,960 | — | ↗ |
| 2020-11-24 | Lee Sam | Officer | A-Award | A | Stock Options (Right to Buy) | 50,000 | 1.30 | 65.0K | 50,000 | — | ↗ |
| 2020-06-22 | WILCOX GARY | Officer | A-Award | A | Stock Options (Right to Buy) | 200,000 | 1.33 | 266.0K | 200,000 | — | ↗ |
| 2020-06-22 | Rubin Steven D | Director | A-Award | A | Stock Options (Right to Buy) | 72,000 | 1.33 | 95.8K | 72,000 | — | ↗ |
| 2020-06-22 | Martin James Joseph | Officer | A-Award | A | Stock Options (Right to Buy) | 150,000 | 1.33 | 199.5K | 150,000 | — | ↗ |
| 2020-06-22 | Lee Sam | Officer | A-Award | A | Stock Options (Right to Buy) | 100,000 | 1.33 | 133.0K | 100,000 | — | ↗ |
| 2020-06-22 | Kornberg Roger D. | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 1.33 | 66.5K | 50,000 | — | ↗ |
| 2020-06-22 | Japour Anthony J | Director | A-Award | A | Stock Options (Right to Buy) | 56,000 | 1.33 | 74.5K | 56,000 | — | ↗ |
| 2020-06-22 | FROST PHILLIP MD ET AL | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 1.33 | 66.5K | 50,000 | — | ↗ |
| 2020-04-15 | Kornberg Roger D. | Director | — | I | Common Stock | 0 | 0.00 | — | 477,217 | — | ↗ |
| 2019-10-25 | Schinazi Raymond F | 10% Owner | P-Purchase | A | Common Stock | 7,906 | 1.15 | 9.1K | 9,257,863 | — | ↗ |
| 2019-10-24 | Schinazi Raymond F | 10% Owner | P-Purchase | A | Common Stock | 5,094 | 1.15 | 5.9K | 9,249,957 | — | ↗ |
| 2019-10-23 | Schinazi Raymond F | 10% Owner | P-Purchase | A | Common Stock | 3,935 | 1.04 | 4.1K | 9,244,863 | — | ↗ |
| 2019-04-04 | Japour Anthony J | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-02-01 | Brady Todd R. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-09-21 | WILCOX GARY | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 200,000 | 2.78 | 556.0K | 200,000 | — | ↗ |
| 2018-09-21 | Schinazi Raymond F | Director / 10% Owner | A-Award | A | Stock Options (Right to Buy) | 50,000 | 2.78 | 139.0K | 50,000 | — | ↗ |
| 2018-09-21 | Rubin Steven D | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 2.78 | 139.0K | 50,000 | — | ↗ |
| 2018-09-21 | Martin James Joseph | Officer | A-Award | A | Stock Options (Right to Buy) | 150,000 | 2.78 | 417.0K | 150,000 | — | ↗ |
| 2018-09-21 | Lee Sam | Officer | A-Award | A | Stock Options (Right to Buy) | 100,000 | 2.78 | 278.0K | 100,000 | — | ↗ |
| 2018-09-21 | HSIAO JANE PH D | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 2.78 | 139.0K | 50,000 | — | ↗ |
| 2018-09-21 | FROST PHILLIP MD ET AL | Director / 10% Owner | A-Award | A | Stock Options (Right to Buy) | 50,000 | 2.78 | 139.0K | 50,000 | — | ↗ |
| 2018-09-21 | BLOCK DAVID S | Director | A-Award | A | Stock Options (Right to Buy) | 50,000 | 2.78 | 139.0K | 50,000 | — | ↗ |
| 2018-05-10 | Schinazi Raymond F | Director / 10% Owner | M-Exempt | A | Common Stock | 263,158 | 1.90 | 500.0K | 985,384 | — | ↗ |
| 2018-05-03 | Schinazi Raymond F | Director / 10% Owner | A-Award | A | Common Stock | 420,737 | 1.90 | 799.4K | 722,226 | — | ↗ |
| 2018-05-03 | FROST PHILLIP MD ET AL | Director / 10% Owner | A-Award | A | Common Stock | 105,263 | 1.90 | 200.0K | 3,655,265 | — | ↗ |
| 2017-11-24 | Schinazi Raymond F | Director | A-Award | A | 8% Convertible Note | 1,851,851 | 0.27 | 500.0K | 1,851,851 | — | ↗ |
| 2017-07-11 | Schinazi Raymond F | Director / 10% Owner | M-Exempt | A | Common Stock | 1,706,978 | 0.05 | 80.2K | 277,227,831 | — | ↗ |
| 2017-04-20 | Schinazi Raymond F | Director / 10% Owner | A-Award | A | Common Stock | 4,166,667 | 0.24 | 1.00M | 9,044,717 | — | ↗ |
| 2017-02-23 | Martin James Joseph | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-12-23 | Lee Sam | — | S-Sale | D | Common Stock | 2,200,000 | 0.44 | 968.0K | 13,087,847 | — | ↗ |
| 2016-09-01 | WILCOX GARY | — | P-Purchase | A | Common Stock | 10,000 | 0.41 | 4.1K | 16,948,605 | — | ↗ |
| 2016-09-01 | Schinazi Raymond F | — | P-Purchase | A | Common Stock | 4,878,050 | 0.41 | 2.00M | 4,878,050 | — | ↗ |
| 2016-09-01 | BLOCK DAVID S | — | P-Purchase | A | Common Stock | 10,000 | 0.41 | 4.1K | 168,696 | — | ↗ |
| 2016-03-15 | WILCOX GARY | — | P-Purchase | A | Common Stock | 49,020 | 0.51 | 25.0K | 16,938,605 | — | ↗ |
| 2016-03-15 | Schinazi Raymond F | — | P-Purchase | A | Common Stock | 2,941,176 | 0.51 | 1.50M | 275,520,853 | — | ↗ |
| 2016-03-15 | Rubin Steven D | — | P-Purchase | A | Common Stock | 39,216 | 0.51 | 20.0K | 93,564 | — | ↗ |
| 2016-03-15 | Meckler Jeffrey A | — | P-Purchase | A | Common Stock | 294,118 | 0.51 | 150.0K | 657,161 | — | ↗ |
| 2016-03-15 | HSIAO JANE PH D | — | P-Purchase | A | Common Stock | 1,235,294 | 0.51 | 630.0K | 3,435,294 | — | ↗ |
| 2016-03-15 | FROST PHILLIP MD ET AL | — | P-Purchase | A | Common Stock | 2,941,177 | 0.51 | 1.50M | 106,500,147 | — | ↗ |
| 2016-03-15 | BLOCK DAVID S | — | P-Purchase | A | Common Stock | 50,000 | 0.51 | 25.5K | 158,696 | — | ↗ |
| 2015-12-23 | Meckler Jeffrey A | — | P-Purchase | A | Common Stock | 100,000 | 0.58 | 57.9K | 363,043 | — | ↗ |
| 2015-11-24 | Dale Curtis | — | A-Award | A | Stock options (Right to Buy) | 100,000 | 0.74 | 74.0K | 100,000 | — | ↗ |
| 2015-11-17 | Dale Curtis | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-10-01 | Meckler Jeffrey A | — | A-Award | A | Stock Option (Right to Buy) | 16,000,000 | 0.70 | 11.20M | 16,000,000 | — | ↗ |
| 2015-10-01 | Mayers Douglas L | — | A-Award | A | Stock Options (Right to buy) | 2,400,000 | 0.70 | 1.68M | 2,400,000 | — | ↗ |
| 2015-07-21 | Linscott Walt Addison | — | A-Award | A | Stock options (right to buy) | 1,200,000 | 0.98 | 1.18M | 1,200,000 | — | ↗ |
| 2015-04-21 | Schinazi Raymond F | — | P-Purchase | A | Common Stock | 3,464,855 | 0.92 | 3.19M | 272,579,677 | — | ↗ |
| 2015-04-13 | Schinazi Raymond F | — | A-Award | A | Stock options (Right to buy) | 350,000 | 1.17 | 409.5K | 350,000 | — | ↗ |
| 2015-04-13 | Rubin Steven D | — | A-Award | A | Stock options (Right to buy) | 350,000 | 1.17 | 409.5K | 350,000 | — | ↗ |
| 2015-04-13 | McGuire Gerald A | — | A-Award | A | Stock options (Right to buy) | 200,000 | 1.17 | 234.0K | 200,000 | — | ↗ |
| 2015-04-13 | HSIAO JANE PH D | — | A-Award | A | Stock options (Right to buy) | 350,000 | 1.17 | 409.5K | 350,000 | — | ↗ |
| 2015-04-13 | FROST PHILLIP MD ET AL | — | A-Award | A | Stock options (Right to buy) | 350,000 | 1.17 | 409.5K | 350,000 | — | ↗ |
| 2015-04-13 | BLOCK DAVID S | — | A-Award | A | Stock options (Right to buy) | 350,000 | 1.17 | 409.5K | 350,000 | — | ↗ |
| 2015-03-25 | WILCOX GARY | — | P-Purchase | A | Common Stock | 54,348 | 0.92 | 50.0K | 16,889,585 | — | ↗ |
| 2015-03-25 | Rubin Steven D | — | P-Purchase | A | Common Stock | 54,348 | 0.92 | 50.0K | 694,268 | — | ↗ |
| 2015-03-25 | Meckler Jeffrey A | — | P-Purchase | A | Common Stock | 163,043 | 0.92 | 150.0K | 263,043 | — | ↗ |
| 2015-03-25 | HSIAO JANE PH D | — | P-Purchase | A | Common Stock | 2,200,000 | 0.92 | 2.02M | 2,200,000 | — | ↗ |
| 2015-03-25 | FROST PHILLIP MD ET AL | — | P-Purchase | A | Common Stock | 3,464,855 | 0.92 | 3.19M | 103,558,969 | — | ↗ |
| 2015-03-25 | BLOCK DAVID S | — | P-Purchase | A | Common Stock | 108,696 | 0.92 | 100.0K | 108,696 | — | ↗ |
| 2015-03-23 | Meckler Jeffrey A | — | A-Award | A | Stock Option (Right to Buy) | 1,750,000 | 1.02 | 1.78M | 1,750,000 | — | ↗ |
| 2015-03-03 | WILCOX GARY | — | M-Exempt | A | Common Stock | 16,835,237 | 0.00 | — | 16,835,237 | — | ↗ |
| 2015-03-03 | Schinazi Raymond F | — | M-Exempt | A | Common Stock | 269,114,822 | 0.00 | — | 269,114,822 | — | ↗ |
| 2015-03-03 | Rubin Steven D | — | M-Exempt | A | Common Stock | 109,920 | 0.00 | — | 639,920 | — | ↗ |
| 2015-03-03 | Lee Sam | — | M-Exempt | A | Common Stock | 15,287,847 | 0.00 | — | 15,287,847 | — | ↗ |
| 2015-03-03 | HSIAO JANE PH D | — | M-Exempt | A | Common Stock | 5,496,654 | 0.00 | — | 5,496,654 | — | ↗ |
| 2015-03-03 | FROST PHILLIP MD ET AL | — | M-Exempt | A | Common Stock | 87,726,389 | 0.00 | — | 100,094,114 | — | ↗ |
| 2014-12-15 | FROST PHILLIP MD ET AL | — | P-Purchase | A | Common Stock | 6,127 | 0.43 | 2.6K | 12,348,852 | — | ↗ |
| 2014-12-11 | Meckler Jeffrey A | — | P-Purchase | A | Common Stock | 50,000 | 0.46 | 23.0K | 100,000 | — | ↗ |
| 2014-11-25 | Schinazi Raymond F | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-11-25 | Meckler Jeffrey A | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-11-25 | BLOCK DAVID S | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-08-12 | FROST PHILLIP MD ET AL | — | P-Purchase | A | Common Stock | 66,200 | 0.29 | 19.4K | 12,342,725 | — | ↗ |
| 2014-08-11 | FROST PHILLIP MD ET AL | — | P-Purchase | A | Common Stock | 45,000 | 0.29 | 13.0K | 12,276,525 | — | ↗ |
| 2014-03-17 | WILCOX GARY | — | — | D | Series B Preferred Stock | 16,835,237 | 0.00 | — | 0 | — | ↗ |
| 2014-03-17 | Rubin Steven D | Director | — | D | Series B Preferred Stock | 109,920 | 0.00 | — | 0 | — | ↗ |
| 2014-03-17 | Opko Health, Inc. | 10% Owner | — | D | Series B Preferred Stock | 34,893,242 | 0.00 | — | 0 | — | ↗ |
| 2014-03-17 | McGuire Gerald A | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-03-17 | Lee Sam | — | — | D | Series B Preferred Stock | 15,287,847 | 0.00 | — | 0 | — | ↗ |
| 2014-03-17 | Kornberg Roger D. | — | — | D | Series B Preferred Stock | 15,287,847 | 0.00 | — | 0 | — | ↗ |
| 2014-03-17 | HSIAO JANE PH D | Director | — | I | Series B Preferred Stock | 5,496,654 | 0.00 | — | 0 | — | ↗ |
| 2014-03-17 | FROST PHILLIP MD ET AL | — | — | I | Series B Preferred Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-01-17 | Opko Health, Inc. | 10% Owner | — | D | Common Stock Warrants | 1,000,000 | 0.50 | 500.0K | 0 | — | ↗ |
| 2013-04-18 | FROST PHILLIP MD ET AL | — | — | I | Common Stock Warrants (Right to Buy) | 200,000 | 0.50 | 100.0K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
10.25M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | James Martin Co-Chief Executive Officer and Chief Financial Officer | 410.5K | 200.0K | 70.4K | — | — | — | 630.2K | 11.17% | ↗ |
| 2 | 2024 | Sam Lee Co-Chief Executive Officer and President | 410.5K | 200.0K | 70.4K | — | — | — | 630.2K | 11.17% | ↗ |
| 3 | 2023 | James Martin Co-Chief Executive Officer and Chief Financial Officer | 394.8K | 165.0K | — | 67.4K | — | — | 627.2K | 10.74% | ↗ |
| 4 | 2023 | Sam Lee Co-Chief Executive Officer and President | 394.8K | 165.0K | — | 67.4K | — | — | 627.2K | 10.74% | ↗ |
| 5 | 2022 | Sam Lee Co-Chief Executive Officer and President | 371.4K | 150.0K | — | 100.2K | — | — | 621.6K | 16.12% | ↗ |
| 6 | 2022 | James Martin Co-Chief Executive Officer and Chief Financial Officer | 371.4K | 150.0K | — | 100.2K | — | — | 621.6K | 16.12% | ↗ |
| 7 | 2021 | James Martin Co-Interim Chief Executive Officer and Chief Financial Officer | 332.5K | 100.0K | — | 232.5K | — | — | 665.0K | 34.96% | ↗ |
| 8 | 2021 | Sam Lee Co-Chief Executive Officer and President | 332.5K | 100.0K | — | 232.5K | — | — | 665.0K | 34.96% | ↗ |
| 9 | 2021 | James Martin Co-Chief Executive Officer and Chief Financial Officer | 332.5K | 100.0K | — | 232.5K | — | — | 665.0K | 34.96% | ↗ |
| 10 | 2021 | Sam Lee Co-Interim Chief Executive Officer and President | 332.5K | 100.0K | — | 232.5K | — | — | 665.0K | 34.96% | ↗ |
| 11 | 2021 | Gary Wilcox Former Chief Executive Officer | 131.3K | — | — | — | — | — | 131.3K | 0.00% | ↗ |
| 12 | 2020 | Gary Wilcox Former Chief Executive Officer | 268.0K | 80.0K | — | 215.0K | — | — | 563.0K | 38.19% | ↗ |
| 13 | 2020 | Gary Wilcox Chief Executive Officer | 268.0K | 80.0K | — | 215.0K | — | — | 563.0K | 38.19% | ↗ |
| 14 | 2020 | James Martin Chief Financial Officer | 281.0K | 50.0K | — | 161.0K | — | — | 492.0K | 32.72% | ↗ |
| 15 | 2020 | James Martin Co-Interim Chief Executive Officer and Chief Financial Officer | 281.0K | 50.0K | — | 161.0K | — | — | 492.0K | 32.72% | ↗ |
| 16 | 2020 | Sam Lee Co-Interim Chief Executive Officer and President | 293.0K | 20.0K | — | 149.0K | — | — | 462.0K | 32.25% | ↗ |
| 17 | 2020 | Sam Lee President | 293.0K | 20.0K | — | 149.0K | — | — | 462.0K | 32.25% | ↗ |
| 18 | 2019 | Sam Lee President | 241.0K | — | — | — | — | — | 241.0K | 0.00% | ↗ |
| 19 | 2019 | James Martin Chief Financial Officer | 231.0K | — | — | — | — | — | 231.0K | 0.00% | ↗ |
| 20 | 2019 | Gary Wilcox Chief Executive Officer | 201.0K | — | — | — | — | — | 201.0K | 0.00% | ↗ |
| 21 | 2018 | Gary Wilcox Chief Executive Officer | 137.0K | — | — | 421.4K | — | — | 558.4K | 75.47% | ↗ |
| 22 | 2018 | James Martin Chief Financial Officer | 230.8K | — | — | 316.1K | — | — | 549.9K | 57.48% | ↗ |
| 23 | 2018 | Sam Lee President | 200.8K | — | — | 210.7K | — | — | 411.5K | 51.20% | ↗ |
| 24 | 2017 | Sam Lee President | 253.3K | — | — | — | — | — | 253.3K | 0.00% | ↗ |
| 25 | 2017 | James Martin Chief Financial Officer | 134.7K | — | — | — | — | 64.9K | 199.6K | 0.00% | ↗ |
| 26 | 2017 | Gary Wilcox Interim Chief Executive Officer | 100.6K | — | — | — | — | — | 100.6K | 0.00% | ↗ |
| 27 | 2017 | Gary Wilcox Chief Executive Officer | 100.6K | — | — | — | — | — | 100.6K | 0.00% | ↗ |
| 28 | 2017 | Curtis Dale Former Interim Chief Financial Officer | 18.9K | 15.9K | — | — | — | — | 34.8K | 0.00% | ↗ |
| 29 | 2016 | Sam Lee President | 260.8K | — | — | — | — | — | 260.8K | 0.00% | ↗ |
| 30 | 2016 | Curtis Dale Former Interim Chief Financial Officer | 197.8K | — | — | — | — | — | 197.8K | 0.00% | ↗ |
| 31 | 2016 | Gary Wilcox Interim Chief Executive Officer | 100.6K | — | — | — | — | — | 100.6K | 0.00% | ↗ |
| 32 | 2015 | Jeffrey Meckler Chief Executive Officer | 214.5K | 140.3K | — | — | — | — | 354.8K | 0.00% | ↗ |
| 33 | 2015 | Gerald McGuire Former Chief Financial Officer | 143.8K | 50.0K | — | — | — | 16.7K | 210.5K | 0.00% | ↗ |
| 34 | 2015 | Sam Lee President | 203.6K | — | — | — | — | — | 203.6K | 0.00% | ↗ |
| 35 | 2015 | Gary Wilcox Former Chief Executive Officer | 133.5K | — | — | — | — | — | 133.5K | 0.00% | ↗ |
| 36 | 2015 | Gary Wilcox Interim Chief Executive Officer | 133.5K | — | — | — | — | — | 133.5K | 0.00% | ↗ |
| 37 | 2015 | Walt Linscott General Counsel and Secretary | 98.4K | 34.4K | — | — | — | — | 132.8K | 0.00% | ↗ |
| 38 | 2015 | Curtis Dale Former Interim Chief Financial Officer | 42.8K | 15.9K | — | 58.5K | — | 15.6K | 132.7K | 44.05% | ↗ |
| 39 | 2015 | Curtis Dale Interim Chief Financial Officer and Controller | 42.8K | 15.9K | — | — | — | 15.6K | 74.6K | 0.00% | ↗ |
| 40 | 2014 | Gary Wilcox Former Chief Executive Officer | 250.0K | — | — | — | — | — | 250.0K | 0.00% | ↗ |
| 41 | 2014 | Gary Wilcox Former Chief Executive Officer | 245.0K | — | — | — | — | — | 245.0K | 0.00% | ↗ |
| 42 | 2014 | Sam Lee President | 180.0K | — | — | — | — | — | 180.0K | 0.00% | ↗ |
| 43 | 2014 | Sam Lee President | 169.9K | — | — | — | — | — | 169.9K | 0.00% | ↗ |
| 44 | 2014 | Gerald McGuire Chief Financial Officer | 100.0K | 50.0K | — | — | — | — | 150.0K | 0.00% | ↗ |
| 45 | 2014 | Gerald McGuire Former Chief Financial Officer | 100.0K | 50.0K | — | — | — | — | 150.0K | 0.00% | ↗ |
| 46 | 2014 | Elliot Maza Former Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 47 | 2013 | Elliot Maza Former Chief Executive Officer | 371.9K | — | — | — | — | — | 371.9K | 0.00% | ↗ |
| 48 | 2013 | Sam Lee President | 160.0K | — | — | — | — | — | 160.0K | 0.00% | ↗ |
| 49 | 2013 | Gary Wilcox Former Chief Executive Officer | 160.0K | — | — | — | — | — | 160.0K | 0.00% | ↗ |
| 50 | 2013 | Gerald McGuire Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 51 | 2013 | Sam Lee President | — | — | — | — | — | — | — | — | ↗ |
| 52 | 2013 | Gary Wilcox Former Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| James J. Martin | Co-CEO, CFO & Corporate Secretary | 265.0K | male |
| Sam Lee | Co-Founder, Co-CEO & President | 248.7K | — |
| Roger D. Kornberg | Co-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board | 100.0K | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for COCP
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
